Skip to content

Clinical trials

Phase 2 Lymphoma, T-Cell, Cutaneous trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Cutaneous Phase: Phase 2 Country / region: United States Clear all

114 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20015
20021
20035
20045
200510
20064
20079
20084
20093
20107
20117
20124
20131
20143
20152
20173
20182
20193
20201
20212
20221
20233
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated20
Recruiting9
Unknown status8
Withdrawn3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center15
National Cancer Institute (NCI)9
Northwestern University6
Case Comprehensive Cancer Center4
M.D. Anderson Cancer Center4
City of Hope Medical Center3
Memorial Sloan Kettering Cancer Center3
Yale University3
Genmab2
Herbert Irving Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Cutaneous114
Mycosis Fungoides79
Sezary Syndrome69
Lymphoma, Non-Hodgkin52
Leukemia, Lymphocytic, Chronic, B-Cell49
Lymphoma49
Lymphoma, B-Cell, Marginal Zone46
Lymphoma, Follicular45
Lymphoma, Large B-Cell, Diffuse45
Precursor Cell Lymphoblastic Leukemia-Lymphoma45

Trials

Showing 1 to 25 of 114. Each trial links to its page on Pharma Observatory.

14 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.